AmpliPhi Biosciences (APHB) Reports Q3 Loss of $0.09

AmpliPhi Biosciences (NYSE: APHB) reported Q3 EPS of ($0.09), versus ($0.30) reported last year. Revenue for the quarter came in at $38 thousand versus the consensus estimate of $29 thousand.

For earnings history and earnings-related data on AmpliPhi Biosciences (APHB) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• GE Vernova T&D India (GVTD:IN) PT Raised to INR5,300 at Emkay Global
• RBC Capital Resumes BorgWarner (BWA) at Outperform